New Jersey Supreme Court Won't Centralize Tylenol Liver Injury Cases

New Jersey Supreme Court Won't Centralize Tylenol Liver Injury Cases

TRENTON, N.J. - The New Jersey Supreme Court has denied an application by the manufacturer of Tylenol products to centralize state court cases alleging liver damage from the nonprescription pain- and fever-reducing drug, according to a notice posted by the court on Aug. 13.

Find full version on lexis Advance®
Access this news story on lexis.com®